ulcerative-colitis

Documents about ulcerative-colitis

• The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis#994728ClinicalTrials.gov
• Decreased CD3+CD56+ Natural Killer T Lymphocytes and Increased Human Leukocyte Antigen-DR+ Cells in the Inflamed Area of Pouchitis in Ulcerative Colitis Patients#455581OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Local and Systemic Immunoprofiling of Patients Diagnosed With Ulcerative Colitis#857212ClinicalTrials.gov
• The Effect of Diet on Disease Activity and Symptoms in Patients With Ulcerative Colitis#1046161ClinicalTrials.gov
• First in Human, Single Ascending Dose Study#864433ClinicalTrials.gov
• Improving ulcerative colitis prospects through fecal microbiota transfer: atypical donor microbiota can boost success rate#374623HAL (France)
• Assessing the proinflammatory potential of sterile fecal microbiome filtrate from ulcerative colitis patients using an intestine-on-chip platform and automated image analysis.#412892PubMed
• Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn's Disease#844772ClinicalTrials.gov
• The Efficacy of Hyperbaric Oxygen-assisted Treatment for ASUC and Refractory IBD#845780ClinicalTrials.gov
• Impact of Additional Treatment With Saccharomyces Boulardii on Quality of Life in Patients With Mild Forms of Ulcerative Colitis and Crohn Disease#886016ClinicalTrials.gov
• Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis#968991ClinicalTrials.gov
• Utility of Low Intensity Pulsed Ultrasound Stimulation (LIPUS) to Modulate the Release of Mediators Capable of Reflecting the Inflammatory State in the Affected Colonic Tract of Ulcerative Colitis Patients#1010300ClinicalTrials.gov
• E-nose in Evaluating Colitis Activity#862962ClinicalTrials.gov
• An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis#831943ClinicalTrials.gov
• Acupuncture for Symptom Relief in Adults with Mild to Moderate Ulcerative Colitis#859975ClinicalTrials.gov
• Metformin as Added on Therapy in Patients With Ulcerative Colitis#18563ClinicalTrials.gov
• UC Cohort - The Influence of Diet on Gut Microbiotas#805437ClinicalTrials.gov
• Microbiota-targeted Diet for Pediatric UC#825961ClinicalTrials.gov
• INSIGHT-IBD Pragmatic Study#979869ClinicalTrials.gov
• Budesonide 9 mg Capsules in Active UC#1044391ClinicalTrials.gov
• Effects of diet, dietary inflammatory index, modified antiinflammatory dietary intervention via diet management platform on short-term prognosis in patients with ulcerative colitis: A prospective study.#123371PubMed
• Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results#643352HAL (France)
• How many risk factors are too many: massive pulmonary embolism in a patient with ulcerative colitis and steroid-induced vertebral fractures: a case report#667421ARPHA OAI-PMH Endpoint
• A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors#873165ClinicalTrials.gov
• Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis#893338ClinicalTrials.gov
• A dataset of endoscopic and biopsy features in ulcerative colitis: a meta-analysis including single-arm rates and odds ratios#11919DataCite
• Table 1_Predictive model for ulcerative colitis therapeutic response using clinical indicators and peripheral blood T-cell subsets.docx#624482Figshare
• Image 1_Predictive model for ulcerative colitis therapeutic response using clinical indicators and peripheral blood T-cell subsets.tiff#624483Figshare
• Colon-targeted doxycycline-procaine azo mutual prodrug attenuates acetic-acid-induced ulcerative colitis in mice via modulation of CRP, IL-6, IL-10, and TNF-α#667777African Journals Online
• Cardiovascular Risk in Patients With IBD#803886ClinicalTrials.gov
• Microplastic Analysis in Pediatric Inflammatory Bowel Disease#876443ClinicalTrials.gov
• Clotrimazole Enemas for Pouchitis in Children and Adults#349978ClinicalTrials.gov
• Inflammatory Bowel Diseases (IBD) Cannabis Registry#886134ClinicalTrials.gov
• Saffron as Anti Inflammatory In Patients With Inflammatory Bowel Disease#969383ClinicalTrials.gov
• A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease#834722ClinicalTrials.gov
• TARGET Registry A Project of the German Network for Intestinal Diseases in Cooperation With Other Corporate Partners#807702ClinicalTrials.gov
• [Advances in the clinical management of acute severe ulcerative colitis].#165880NCBI PubMed Central
• Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context#868457ClinicalTrials.gov
• A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis#884547ClinicalTrials.gov
• Table 1_Protective effects and possible mechanisms of matrine-type alkaloids (matrine and oxymatrine) in animal models of ulcerative colitis: a preclinical systematic review and meta-analysis.docx#395072Figshare
• A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)#915240ClinicalTrials.gov
• Characterization of Computed Tomography Colonography Findings of Ulcerative Colitis-Associated Neoplasia.#152295NCBI PubMed Central
• Single-cell profiling reveals diverse γδ T cell subsets in ulcerative colitis.#285082NCBI PubMed Central
• Cannabidiol for Inflammatory Bowel Disease#834736ClinicalTrials.gov
• Biomarkers in Inflammatory Bowel Diseases#870577ClinicalTrials.gov
• Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.#911688ClinicalTrials.gov
• Xeljanz Special Investigation for Long-term Use in UC Patients#914535ClinicalTrials.gov
• Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults#1045518ClinicalTrials.gov
• Image 1_Machine learning–driven identification and experimental validation of key biomarkers in the bile acid metabolic pathway associated with ulcerative colitis.png#480324Figshare
• Table 1_Machine learning–driven identification and experimental validation of key biomarkers in the bile acid metabolic pathway associated with ulcerative colitis.docx#480325Figshare